SGK2
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15530 | S176 | Sugiyama | PDPK1 PDK1 | YFGLSYAKNGELLKYIRKIGsFDETCTRFYTAEIVSALEYL |
| O43175 | T78 | Sugiyama | PHGDH PGDH3 | KVTADVINAAEKLQVVGRAGtGVDNVDLEAAtRKGILVMNT |
| O43390 | S428 | Sugiyama | HNRNPR HNRPR | LAKPPDKKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRG |
| O43524 | S253 | SIGNOR|ELM | FOXO3 FKHRL1 FOXO3A | WWIINPDGGKsGKAPRRRAVsMDNsNKYTKSRGRAAKKKAA |
| O43524 | S315 | ELM | FOXO3 FKHRL1 FOXO3A | PtSRssDELDAWTDFRsRTNsNAsTVsGRLSPIMAsTELDE |
| O43524 | T32 | SIGNOR|ELM | FOXO3 FKHRL1 FOXO3A | sPLEVELDPEFEPQSRPRsCtWPLQRPELQAsPAKPSGETA |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O43847 | S96 | Sugiyama | NRDC NRD1 | SRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYRYI |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60271 | T595 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | NLKYNAPTSHVtPsVKKRsstLsQLPGDKSKAFDFLSEETE |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60739 | T45 | Sugiyama | EIF1B | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75369 | S1442 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | SKVKIAGPGLGsGVRARVLQsFtVDSSKAGLAPLEVRVLGP |
| O75937 | S81 | Sugiyama | DNAJC8 SPF31 HSPC315 HSPC331 | VLQIDPEVTDEEIKKRFRQLsILVHPDKNQDDADRAQKAFE |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| P00491 | S163 | Sugiyama | PNP NP | GQNPLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGE |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P0CAP2 | S179 | Sugiyama | POLR2M GRINL1A | RDRVPPSSEASEHHPRHRVssQAEDtSssFDNLFIDRLQRI |
| P0CAP2 | T184 | Sugiyama | POLR2M GRINL1A | PSSEASEHHPRHRVssQAEDtSssFDNLFIDRLQRITIADQ |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P13010 | S318 | Sugiyama | XRCC5 G22P2 | NDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSEGK |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13796 | S5 | PSP | LCP1 PLS2 | ________________MARGsVsDEEMMELREAFAKVDtDG |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15056 | S365 | ELM | BRAF BRAF1 RAFB1 | PFRPADEDHRNQFGQRDRsssAPNVHINtIEPVNIDDLIRD |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17655 | T464 | Sugiyama | CAPN2 CANPL2 | TNIHLSKNFFLTNRARERsDtFINLREVLNRFKLPPGEYIL |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P18583 | S2011 | Sugiyama | SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312 | RSRTPSRRRRSRSVVRRRsFsIsPVRLRRSRTPLRRRFsRs |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P20810 | S366 | Sugiyama | CAST | DKDGKPLLPEPEEKPKPRsEsELIDELsEDFDRsECKEKPS |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41567 | T45 | Sugiyama | EIF1 SUI1 | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48048 | S44 | ELM | KCNJ1 ROMK1 | LRKWVVTRFFGHSRQRARLVsKDGRCNIEFGNVEAQSRFIF |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | T700 | Sugiyama | NASP | sGFtPGGGGssVsMIASRKPtDGAsssNCVTDIsHLVRKKR |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49753 | T118 | Sugiyama | ACOT2 PTE2 PTE2A | ASLRDEKGALFQAHARyRADtLGELDLERAPALGGSFAGLE |
| P49753 | Y114 | Sugiyama | ACOT2 PTE2 PTE2A | VTLRASLRDEKGALFQAHARyRADtLGELDLERAPALGGSF |
| P49841 | S21 | ELM | GSK3B | MSGRPRttsFAEsCKPVQQPsAFGsMKVSRDKDGSKVTTVV |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T598 | Sugiyama | FXR2 FMR1L2 | DESRPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRA |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S21 | Sugiyama | TPI1 TPI | MAPSRKFFVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q00987 | S166 | PSP | MDM2 | KPSSSHLVSRPstSSRRRAIsEtEENsDELsGERQRKRHKs |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q06124 | S134 | Sugiyama | PTPN11 PTP2C SHPTP2 | HGHLSGKEAEKLLTEKGKHGsFLVREsQsHPGDFVLSVRTG |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q12778 | S256 | ELM | FOXO1 FKHR FOXO1A | WWMLNPEGGKSGKsPRRRAAsMDNNSKFAKSRSRAAKKKAs |
| Q12778 | S319 | ELM | FOXO1 FKHR FOXO1A | PGsHsNDDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLG |
| Q12778 | T24 | ELM | FOXO1 FKHR FOXO1A | APQVVEIDPDFEPLPRPRsCtWPLPRPEFSQSNSATSSPAP |
| Q12931 | T494 | Sugiyama | TRAP1 HSP75 HSPC5 | ALPsGQLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyy |
| Q12965 | T936 | Sugiyama | MYO1E MYO1C | LQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAP |
| Q12982 | S114 | Sugiyama | BNIP2 NIP2 | EFEWEDDLPKPKTTEVIRKGsItEyTAAEEKEDGRRWRMFR |
| Q13206 | S831 | Sugiyama | DDX10 | DMENKISDTKKKQGMKKRsNsEVEDVGPTsHNRKKARWDTL |
| Q13439 | S41 | Sugiyama | GOLGA4 | APAQAssNsstPtRMRsRtssFtEQLDEGtPNRESGDTQSF |
| Q13439 | T39 | Sugiyama | GOLGA4 | ALAPAQAssNsstPtRMRsRtssFtEQLDEGtPNRESGDTQ |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13501 | S28 | Sugiyama | SQSTM1 ORCA OSIL | AYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPCERLL |
| Q13586 | S618 | Sugiyama | STIM1 GOK | ELsPsAPPGGsPHLDssRsHsPssPDPDtPsPVGDSRALQA |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14432 | S312 | Sugiyama | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15751 | S1514 | Sugiyama | HERC1 | AESRLVHtsPNYRLIKsRsEsDLsQPEsDEEGYALsGRRNV |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16637 | S28 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | sGGGVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDKAVA |
| Q16637 | S31 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | GVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDKAVAsFK |
| Q3KQU3 | S116 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | PtPPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEVKKAG |
| Q4G0J3 | S300 | Sugiyama | LARP7 HDCMA18P | DRVEAssLPEVRTGKRKRsssEDAEsLAPRSKVKKIIQKDI |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5T1M5 | S1161 | Sugiyama | FKBP15 KIAA0674 | TEAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALR |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5VTB9 | T368 | Sugiyama | RNF220 C1orf164 | ENNNRFEEYEWCGQKRIRATtLLEGGFRGSGFIMCSGKENP |
| Q6A1A2 | S149 | Sugiyama | PDPK2P PDPK2 | YFGLSYAKNGELLKYIRKIGsFDETCTRFYTAEIVSALEYL |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q86TX2 | T56 | Sugiyama | ACOT1 CTE1 | ASLRDEKGALFQAHARyRADtLGELDLERAPALGGSFAGLE |
| Q86TX2 | Y52 | Sugiyama | ACOT1 CTE1 | VTLRASLRDEKGALFQAHARyRADtLGELDLERAPALGGSF |
| Q86U44 | S219 | Sugiyama | METTL3 MTA70 | NSSASEPAKEPAKKSRKHAAsDVDLEIESLLNQQSTKEQQS |
| Q86V48 | S996 | Sugiyama | LUZP1 | RRVGPSSGDAPEPSSRRtQssLtVSEVLTRRNRVGDTITVA |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86YD1 | S36 | PSP | PTOV1 ACID2 PP642 UNQ6127/PRO20092 | PLGGRGRPPRPLVVRAVRsRsWPASPRGPQPPRIRARsAPP |
| Q86YD1 | S53 | PSP | PTOV1 ACID2 PP642 UNQ6127/PRO20092 | RsRsWPASPRGPQPPRIRARsAPPMEGARVFGALGPIGPss |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBJ7 | T273 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | RGAsWIDtADGsANHRARVttRMGNtPDsAsDNLGFRCAAD |
| Q8TD19 | S332 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | RREMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVW |
| Q8TE77 | S37 | Sugiyama | SSH3 SSH3L | tPVGPWDQAVQRRSRLQRRQsFAVLRGAVLGLQDGGDNDDA |
| Q8WYP5 | T1277 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | tPKKCAVPVETEWLKSKDRttsFFLNsPEKEHQEMDEGsQs |
| Q92597 | S330 | ELM|Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92597 | T328 | ELM | NDRG1 CAP43 DRG1 RTP | FVQGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSE |
| Q92597 | T346 | ELM | NDRG1 CAP43 DRG1 RTP | sRtAsGssVtsLDGtRsRsHtSEGTRsRsHtsEGtRsRsHt |
| Q92597 | T356 | ELM | NDRG1 CAP43 DRG1 RTP | sLDGtRsRsHtSEGTRsRsHtsEGtRsRsHtsEGAHLDItP |
| Q92597 | T375 | Sugiyama | NDRG1 CAP43 DRG1 RTP | HtsEGtRsRsHtsEGAHLDItPNsGAAGNsAGPKSMEVSC_ |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96G46 | S236 | Sugiyama | DUS3L | QQLRKREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPR |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96PU5 | S342 | ELM | NEDD4L KIAA0439 NEDL3 | NGEQFsSLIQREPssRLRsCsVtDAVAEQGHLPPPSAPAGR |
| Q96PU5 | S448 | ELM | NEDD4L KIAA0439 NEDL3 | sATNSNNHLIEPQIRRPRsLssPtVTLSAPLEGAKDsPVRR |
| Q96PU5 | T367 | ELM | NEDD4L KIAA0439 NEDL3 | VAEQGHLPPPSAPAGRARsstVtGGEEPTPsVAYVHttPGL |
| Q96RU3 | Y500 | Sugiyama | FNBP1 FBP17 KIAA0554 | AEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREsPDG |
| Q96T58 | S1268 | Sugiyama | SPEN KIAA0929 MINT SHARP | SRQISEDsERtGGsPsVRHGsFHEDEDPIGsPRLLSVKGsP |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99759 | S166 | ELM | MAP3K3 MAPKKK3 MEKK3 | QsAGDINtIyQPPEPRsRHLsVssQNPGRssPPPGYVPERQ |
| Q99759 | S337 | ELM | MAP3K3 MAPKKK3 MEKK3 | tNGENMGLAVQYLDPRGRLRsADsENALsVQERNVPTKsPs |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9H0H5 | T251 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | EAVSTIETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPRTE |
| Q9H2U1 | S167 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | LINQEKKMFRIRNRsyIDRDsEyLLQENEPDGtLDQKLLED |
| Q9H3Q1 | S311 | Sugiyama | CDC42EP4 BORG4 CEP4 | PsPGsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPDRA |
| Q9H4A3 | T2245 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | TVNSQAAQAQPPAMTSSRKGtFtDDLHKLVDNWARDAMNLS |
| Q9H4A3 | T2247 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | NSQAAQAQPPAMTSSRKGtFtDDLHKLVDNWARDAMNLSGR |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9HA77 | S548 | Sugiyama | CARS2 OK/SW-cl.10 | TLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG____ |
| Q9NTI5 | S1257 | Sugiyama | PDS5B APRIN AS3 KIAA0979 | LVQEQKPKGSQRSRKRGHtAsEsDEQQWPEEKRLKEDILEN |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9NVR5 | S773 | Sugiyama | DNAAF2 C14orf104 KTU | EFIKEKSATCSNEEKDNLNEsVITEEKETDGDHLsSLLNKT |
| Q9NZN5 | S1288 | Sugiyama | ARHGEF12 KIAA0382 LARG | GLTEKsVQEDWQHFPRyRtAsQGPQtDSVIQNSENIKAyHs |
| Q9NZN5 | T1293 | Sugiyama | ARHGEF12 KIAA0382 LARG | sVQEDWQHFPRyRtAsQGPQtDSVIQNSENIKAyHsGEGHM |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UGV2 | S327 | Sugiyama | NDRG3 | KYFLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsV |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | T329 | Sugiyama | NDRG3 | FLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVts |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9ULL1 | T617 | Sugiyama | PLEKHG1 KIAA1209 | ETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTRELQNSPKT |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UN36 | S332 | ELM | NDRG2 KIAA1248 SYLD | QGMGYMASSCMTRLsRsRtAsLtsAAsVDGNRsRsRtLsQs |
| Q9UN36 | T330 | ELM | NDRG2 KIAA1248 SYLD | FLQGMGYMASSCMTRLsRsRtAsLtsAAsVDGNRsRsRtLs |
| Q9UN36 | T348 | ELM | NDRG2 KIAA1248 SYLD | sRtAsLtsAAsVDGNRsRsRtLsQssEsGtLsSGPPGHTME |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2V2 | S52 | ELM | CARHSP1 | sPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCKCFCR |
| Q9Y3S1 | T2157 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | GPQPALHVQAQVNNSNNKKGtFtDDLHKLVDEWTSKTVGAA |
| Q9Y3S1 | T2159 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | QPALHVQAQVNNSNNKKGtFtDDLHKLVDEWTSKTVGAAQL |
| Q9Y6D5 | S277 | Sugiyama | ARFGEF2 ARFGEP2 BIG2 | RSDSGKVSTENGDAPRERGssLsGtDDGAQEVVKDILEDVV |
| Q9Y6X9 | S739 | Sugiyama | MORC2 KIAA0852 ZCWCC1 | VVKKtEsPIKLsPAtPsRKRsVAVsDEEEVEEEAERRKERC |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.887379e-15 | 14.724 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.961898e-14 | 13.225 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.086908e-13 | 12.964 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.097656e-13 | 12.149 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.778666e-12 | 11.556 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.800793e-11 | 10.745 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.488265e-11 | 10.457 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.728367e-10 | 9.172 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.963576e-09 | 8.528 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.638338e-09 | 8.064 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.850539e-08 | 7.414 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.196850e-08 | 7.377 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.627466e-08 | 7.118 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.357070e-07 | 6.867 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.471669e-07 | 6.832 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.589445e-07 | 6.799 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.715971e-07 | 6.566 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.134356e-07 | 6.504 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.511195e-07 | 6.259 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.038869e-07 | 6.219 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.225003e-07 | 6.085 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.906100e-07 | 6.102 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.212933e-07 | 6.036 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.049326e-06 | 5.979 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.030248e-06 | 5.987 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.030248e-06 | 5.987 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.294538e-06 | 5.888 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.298644e-06 | 5.887 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.377737e-06 | 5.861 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.544887e-06 | 5.811 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.684506e-06 | 5.774 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.777728e-06 | 5.750 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.737034e-06 | 5.563 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.213989e-06 | 5.493 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.630650e-06 | 5.440 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.806475e-06 | 5.419 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.199476e-06 | 5.377 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.903290e-06 | 5.229 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.443104e-06 | 5.191 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.525105e-06 | 5.185 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.084714e-06 | 5.150 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.969935e-06 | 5.099 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.969935e-06 | 5.099 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.946367e-06 | 5.100 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.643608e-06 | 5.117 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.040936e-06 | 5.095 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.395415e-06 | 5.076 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.022910e-05 | 4.990 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.063060e-05 | 4.973 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.100033e-05 | 4.959 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.281327e-05 | 4.892 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.325704e-05 | 4.878 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.359610e-05 | 4.867 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.489879e-05 | 4.827 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.489879e-05 | 4.827 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.504185e-05 | 4.823 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.514367e-05 | 4.820 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.593841e-05 | 4.798 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.617616e-05 | 4.791 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.778639e-05 | 4.750 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.086882e-05 | 4.681 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.208180e-05 | 4.656 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.188287e-05 | 4.660 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.384767e-05 | 4.623 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.392711e-05 | 4.621 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.629888e-05 | 4.580 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.813344e-05 | 4.551 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.747406e-05 | 4.561 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.975023e-05 | 4.527 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.726563e-05 | 4.429 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.552490e-05 | 4.342 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.162855e-05 | 4.287 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.953038e-05 | 4.305 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.287527e-05 | 4.277 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.533011e-05 | 4.257 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.959333e-05 | 4.225 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.116417e-05 | 4.214 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.252431e-05 | 4.204 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.341794e-05 | 4.198 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.767924e-05 | 4.170 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.703174e-05 | 4.174 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.767924e-05 | 4.170 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.992793e-05 | 4.155 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.850156e-05 | 4.105 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.006398e-05 | 4.097 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.803445e-05 | 4.108 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.741318e-05 | 4.058 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.700290e-05 | 4.013 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.734960e-05 | 4.012 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.040233e-04 | 3.983 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.049561e-04 | 3.979 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.097587e-04 | 3.960 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.191575e-04 | 3.924 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.216964e-04 | 3.915 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.219976e-04 | 3.914 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.409223e-04 | 3.851 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.481510e-04 | 3.829 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.495948e-04 | 3.825 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.563784e-04 | 3.806 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.583551e-04 | 3.800 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.583574e-04 | 3.800 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.651358e-04 | 3.782 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.792281e-04 | 3.747 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.889575e-04 | 3.724 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.924744e-04 | 3.716 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.114086e-04 | 3.675 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.972191e-04 | 3.705 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.114086e-04 | 3.675 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.193373e-04 | 3.659 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.212047e-04 | 3.655 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.384801e-04 | 3.623 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.447951e-04 | 3.611 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.561277e-04 | 3.592 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.784425e-04 | 3.555 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.977982e-04 | 3.526 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.039938e-04 | 3.517 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.256264e-04 | 3.487 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.450942e-04 | 3.462 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.450942e-04 | 3.462 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.450942e-04 | 3.462 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.450942e-04 | 3.462 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.581867e-04 | 3.446 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.869416e-04 | 3.412 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.689058e-04 | 3.433 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.689058e-04 | 3.433 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.711805e-04 | 3.430 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.388987e-04 | 3.358 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.430304e-04 | 3.354 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.515225e-04 | 3.345 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.515225e-04 | 3.345 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.649311e-04 | 3.333 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.189666e-04 | 3.285 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.615626e-04 | 3.251 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.615626e-04 | 3.251 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.644023e-04 | 3.248 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.671122e-04 | 3.246 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.923276e-04 | 3.227 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.330286e-04 | 3.199 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.396432e-04 | 3.194 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.396432e-04 | 3.194 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.839815e-04 | 3.165 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.839815e-04 | 3.165 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.404104e-04 | 3.131 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.563823e-04 | 3.121 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.563823e-04 | 3.121 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.721962e-04 | 3.112 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.321690e-04 | 3.080 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.968283e-04 | 3.099 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.279856e-04 | 3.082 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.627175e-04 | 3.064 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.873206e-04 | 3.052 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 9.071127e-04 | 3.042 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.738283e-04 | 3.012 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.746003e-04 | 3.011 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.909566e-04 | 3.004 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.964420e-04 | 3.002 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.129717e-03 | 2.947 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.143407e-03 | 2.942 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.153972e-03 | 2.938 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.176132e-03 | 2.930 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.234464e-03 | 2.909 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.240251e-03 | 2.906 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.255730e-03 | 2.901 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.419385e-03 | 2.848 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.347625e-03 | 2.870 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.419385e-03 | 2.848 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.277442e-03 | 2.894 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.419385e-03 | 2.848 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.319783e-03 | 2.879 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.529174e-03 | 2.816 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.545528e-03 | 2.811 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.622553e-03 | 2.790 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.640113e-03 | 2.785 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.690116e-03 | 2.772 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.761587e-03 | 2.754 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.766248e-03 | 2.753 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.796846e-03 | 2.745 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.125365e-03 | 2.673 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.032850e-03 | 2.692 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.032850e-03 | 2.692 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.975317e-03 | 2.704 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.975317e-03 | 2.704 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.199182e-03 | 2.658 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.965101e-03 | 2.707 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.980601e-03 | 2.703 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.199182e-03 | 2.658 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.045321e-03 | 2.689 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.980601e-03 | 2.703 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.980601e-03 | 2.703 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.203203e-03 | 2.657 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.203852e-03 | 2.657 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.260939e-03 | 2.646 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.493406e-03 | 2.603 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.493406e-03 | 2.603 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.493406e-03 | 2.603 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.605350e-03 | 2.584 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.605400e-03 | 2.584 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.609235e-03 | 2.583 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.805016e-03 | 2.552 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.865874e-03 | 2.543 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.865874e-03 | 2.543 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.186955e-03 | 2.497 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.186955e-03 | 2.497 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.280833e-03 | 2.484 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.280833e-03 | 2.484 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.417886e-03 | 2.466 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.069724e-03 | 2.513 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.069724e-03 | 2.513 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.490771e-03 | 2.457 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.143307e-03 | 2.503 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.186955e-03 | 2.497 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.070023e-03 | 2.513 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.417886e-03 | 2.466 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.070023e-03 | 2.513 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.534781e-03 | 2.452 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.571511e-03 | 2.447 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.599064e-03 | 2.444 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.599064e-03 | 2.444 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.648442e-03 | 2.438 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.648442e-03 | 2.438 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.648442e-03 | 2.438 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.648442e-03 | 2.438 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.648442e-03 | 2.438 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.758543e-03 | 2.425 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.777908e-03 | 2.423 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.813798e-03 | 2.419 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.114906e-03 | 2.386 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.199828e-03 | 2.377 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.387703e-03 | 2.358 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.585365e-03 | 2.339 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.596875e-03 | 2.252 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.596875e-03 | 2.252 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.596875e-03 | 2.252 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.596875e-03 | 2.252 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.596875e-03 | 2.252 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.596875e-03 | 2.252 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.596875e-03 | 2.252 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.596875e-03 | 2.252 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.596875e-03 | 2.252 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.596875e-03 | 2.252 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.596875e-03 | 2.252 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.773622e-03 | 2.321 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.875044e-03 | 2.312 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.810550e-03 | 2.318 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.495461e-03 | 2.260 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.299063e-03 | 2.276 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.773622e-03 | 2.321 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.596316e-03 | 2.252 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.315666e-03 | 2.274 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.534630e-03 | 2.257 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.495461e-03 | 2.260 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.495461e-03 | 2.260 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.198249e-03 | 2.284 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.634994e-03 | 2.249 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.748060e-03 | 2.240 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.748060e-03 | 2.240 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.794124e-03 | 2.237 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 5.864721e-03 | 2.232 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 5.864721e-03 | 2.232 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.913513e-03 | 2.228 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.016695e-03 | 2.221 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.372605e-03 | 2.196 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.372605e-03 | 2.196 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.372605e-03 | 2.196 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.533422e-03 | 2.185 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.662076e-03 | 2.176 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.751474e-03 | 2.171 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.964673e-03 | 2.157 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.392894e-03 | 2.131 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.392894e-03 | 2.131 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.392894e-03 | 2.131 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.098059e-03 | 2.092 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.130630e-03 | 2.090 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.149049e-03 | 2.089 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.356021e-03 | 2.078 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.523353e-03 | 2.069 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 8.551688e-03 | 2.068 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.599071e-03 | 2.066 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.599071e-03 | 2.066 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.772949e-03 | 2.057 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.791436e-03 | 2.056 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.137434e-03 | 2.039 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.641213e-03 | 2.016 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.649099e-03 | 2.016 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.649099e-03 | 2.016 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.879756e-03 | 2.005 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.879756e-03 | 2.005 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.916842e-03 | 2.004 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.249005e-02 | 1.903 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.249005e-02 | 1.903 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.131250e-02 | 1.946 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.099238e-02 | 1.959 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.093229e-02 | 1.961 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.086132e-02 | 1.964 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.249005e-02 | 1.903 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.165783e-02 | 1.933 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.146105e-02 | 1.941 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.176309e-02 | 1.929 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.189073e-02 | 1.925 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.165783e-02 | 1.933 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.131250e-02 | 1.946 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.086132e-02 | 1.964 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.146105e-02 | 1.941 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.288578e-02 | 1.890 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.288578e-02 | 1.890 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.305108e-02 | 1.884 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.315793e-02 | 1.881 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.315793e-02 | 1.881 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.317201e-02 | 1.880 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.317201e-02 | 1.880 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.362359e-02 | 1.866 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.367339e-02 | 1.864 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.367339e-02 | 1.864 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.374493e-02 | 1.862 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.379486e-02 | 1.860 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.379486e-02 | 1.860 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.379486e-02 | 1.860 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.379486e-02 | 1.860 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.379486e-02 | 1.860 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.455706e-02 | 1.837 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.474222e-02 | 1.831 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.479766e-02 | 1.830 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.480124e-02 | 1.830 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.552764e-02 | 1.809 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.552764e-02 | 1.809 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.660607e-02 | 1.780 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.660607e-02 | 1.780 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.674038e-02 | 1.776 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.708541e-02 | 1.767 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.708541e-02 | 1.767 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.708541e-02 | 1.767 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.732342e-02 | 1.761 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.765463e-02 | 1.753 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.771090e-02 | 1.752 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.771090e-02 | 1.752 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.807171e-02 | 1.743 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.881803e-02 | 1.725 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.939715e-02 | 1.712 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.943184e-02 | 1.711 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.092120e-02 | 1.679 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.092120e-02 | 1.679 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.110234e-02 | 1.676 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.110234e-02 | 1.676 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.145062e-02 | 1.669 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.155162e-02 | 1.667 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.155162e-02 | 1.667 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.160642e-02 | 1.665 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.261382e-02 | 1.646 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.785181e-02 | 1.555 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.487538e-02 | 1.604 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.487538e-02 | 1.604 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.501362e-02 | 1.602 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.884153e-02 | 1.540 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.884153e-02 | 1.540 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.743890e-02 | 1.562 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.559468e-02 | 1.592 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.358205e-02 | 1.627 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.637933e-02 | 1.579 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.786040e-02 | 1.555 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.279433e-02 | 1.642 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.785181e-02 | 1.555 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.263247e-02 | 1.645 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.870118e-02 | 1.542 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.555773e-02 | 1.592 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.785181e-02 | 1.555 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.559468e-02 | 1.592 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.261382e-02 | 1.646 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.884153e-02 | 1.540 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.261382e-02 | 1.646 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.279433e-02 | 1.642 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.387672e-02 | 1.622 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.377702e-02 | 1.624 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.214718e-02 | 1.655 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.168270e-02 | 1.664 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.413178e-02 | 1.617 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.610371e-02 | 1.583 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.332760e-02 | 1.632 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.906609e-02 | 1.537 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.911530e-02 | 1.536 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.911530e-02 | 1.536 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.929887e-02 | 1.533 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.929887e-02 | 1.533 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.930290e-02 | 1.533 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.940610e-02 | 1.532 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.104737e-02 | 1.508 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.104737e-02 | 1.508 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.149600e-02 | 1.502 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.149600e-02 | 1.502 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.206269e-02 | 1.494 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.206269e-02 | 1.494 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.227433e-02 | 1.491 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.291452e-02 | 1.483 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.291452e-02 | 1.483 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.304672e-02 | 1.481 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 3.356929e-02 | 1.474 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.356929e-02 | 1.474 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.356929e-02 | 1.474 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.420946e-02 | 1.466 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.420946e-02 | 1.466 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.420946e-02 | 1.466 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.420946e-02 | 1.466 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.464757e-02 | 1.460 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.464757e-02 | 1.460 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.496787e-02 | 1.456 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.504380e-02 | 1.455 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.600203e-02 | 1.444 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.764172e-02 | 1.424 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.764172e-02 | 1.424 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.764172e-02 | 1.424 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.764172e-02 | 1.424 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.921009e-02 | 1.407 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.950035e-02 | 1.403 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.996521e-02 | 1.398 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.996521e-02 | 1.398 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 3.996521e-02 | 1.398 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.996521e-02 | 1.398 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.368158e-02 | 1.360 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.378264e-02 | 1.359 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.494266e-02 | 1.347 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.512650e-02 | 1.346 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.554869e-02 | 1.342 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.558179e-02 | 1.341 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.630558e-02 | 1.334 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 4.705226e-02 | 1.327 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.705226e-02 | 1.327 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.705731e-02 | 1.327 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.804285e-02 | 1.318 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.804285e-02 | 1.318 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.822001e-02 | 1.317 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.822001e-02 | 1.317 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.822001e-02 | 1.317 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.938972e-02 | 1.306 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.938972e-02 | 1.306 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.264528e-02 | 1.139 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 7.264528e-02 | 1.139 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.964168e-02 | 1.224 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.964168e-02 | 1.224 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.456155e-02 | 1.127 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.456155e-02 | 1.127 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.456155e-02 | 1.127 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.464738e-02 | 1.262 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.464738e-02 | 1.262 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.516566e-02 | 1.186 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.483741e-02 | 1.261 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.388074e-02 | 1.131 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.955141e-02 | 1.225 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.955141e-02 | 1.225 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.801042e-02 | 1.167 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.322909e-02 | 1.135 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.322909e-02 | 1.135 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.823427e-02 | 1.166 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.901276e-02 | 1.161 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.332205e-02 | 1.198 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.386540e-02 | 1.269 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.516566e-02 | 1.186 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.182114e-02 | 1.144 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.346719e-02 | 1.197 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.386540e-02 | 1.269 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.648693e-02 | 1.177 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.332205e-02 | 1.198 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.648693e-02 | 1.177 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.550840e-02 | 1.184 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.235683e-02 | 1.141 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.263504e-02 | 1.279 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.394758e-02 | 1.268 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.182114e-02 | 1.144 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.182114e-02 | 1.144 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.394758e-02 | 1.268 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.388074e-02 | 1.131 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.198059e-02 | 1.284 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.876068e-02 | 1.231 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.199828e-02 | 1.284 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.199828e-02 | 1.284 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.250224e-02 | 1.140 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.011050e-02 | 1.221 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.011050e-02 | 1.221 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.452869e-02 | 1.128 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.394758e-02 | 1.268 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.482052e-02 | 1.188 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.978855e-02 | 1.223 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.388074e-02 | 1.131 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.352610e-02 | 1.271 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.352610e-02 | 1.271 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.648693e-02 | 1.177 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.964168e-02 | 1.224 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.678172e-02 | 1.175 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.388074e-02 | 1.131 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.531823e-02 | 1.185 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.464738e-02 | 1.262 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.464738e-02 | 1.262 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.483741e-02 | 1.261 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.516566e-02 | 1.186 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.901276e-02 | 1.161 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.154768e-02 | 1.145 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.483741e-02 | 1.261 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.496620e-02 | 1.125 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.552346e-02 | 1.122 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.552346e-02 | 1.122 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.552346e-02 | 1.122 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.704375e-02 | 1.113 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.718667e-02 | 1.112 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.061432e-02 | 1.094 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.130300e-02 | 1.090 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.140737e-02 | 1.089 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.140737e-02 | 1.089 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.140737e-02 | 1.089 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.303090e-02 | 1.081 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.309893e-02 | 1.080 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.309893e-02 | 1.080 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.309893e-02 | 1.080 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.309893e-02 | 1.080 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.309893e-02 | 1.080 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 8.429485e-02 | 1.074 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 8.429485e-02 | 1.074 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 8.429485e-02 | 1.074 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 8.429485e-02 | 1.074 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.429485e-02 | 1.074 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 8.429485e-02 | 1.074 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 8.429485e-02 | 1.074 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.551797e-02 | 1.068 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.551797e-02 | 1.068 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.583329e-02 | 1.066 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.880726e-02 | 1.052 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.894303e-02 | 1.051 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.935958e-02 | 1.049 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.095205e-02 | 1.041 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.095205e-02 | 1.041 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 9.095205e-02 | 1.041 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.095205e-02 | 1.041 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.095205e-02 | 1.041 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.124242e-02 | 1.040 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.219174e-02 | 1.035 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.290848e-02 | 1.032 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.290848e-02 | 1.032 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.290848e-02 | 1.032 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.408722e-02 | 1.026 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.441114e-02 | 1.025 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.494682e-02 | 1.023 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.494682e-02 | 1.023 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.565889e-02 | 1.019 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.598900e-02 | 1.018 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.628214e-02 | 1.016 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.773354e-02 | 1.010 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 9.889227e-02 | 1.005 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.889227e-02 | 1.005 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.006373e-01 | 0.997 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.017985e-01 | 0.992 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.017985e-01 | 0.992 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.019015e-01 | 0.992 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.019015e-01 | 0.992 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.024294e-01 | 0.990 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.024294e-01 | 0.990 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.024294e-01 | 0.990 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.024294e-01 | 0.990 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.041026e-01 | 0.983 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.041026e-01 | 0.983 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.069288e-01 | 0.971 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.086869e-01 | 0.964 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.087236e-01 | 0.964 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.093152e-01 | 0.961 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.103190e-01 | 0.957 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.115140e-01 | 0.953 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.119080e-01 | 0.951 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.139988e-01 | 0.943 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.155261e-01 | 0.937 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.155261e-01 | 0.937 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.157226e-01 | 0.937 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.160560e-01 | 0.935 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.166203e-01 | 0.933 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.166203e-01 | 0.933 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.170909e-01 | 0.931 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.170909e-01 | 0.931 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.183436e-01 | 0.927 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.188948e-01 | 0.925 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.196224e-01 | 0.922 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.202813e-01 | 0.920 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.206525e-01 | 0.918 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.225066e-01 | 0.912 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.225066e-01 | 0.912 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.230602e-01 | 0.910 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.249538e-01 | 0.903 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.253215e-01 | 0.902 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.253215e-01 | 0.902 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.253215e-01 | 0.902 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.254505e-01 | 0.902 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.273052e-01 | 0.895 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.273052e-01 | 0.895 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.273052e-01 | 0.895 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.276316e-01 | 0.894 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.276316e-01 | 0.894 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.276316e-01 | 0.894 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.276316e-01 | 0.894 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.283626e-01 | 0.892 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.285001e-01 | 0.891 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.285001e-01 | 0.891 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.312505e-01 | 0.882 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.316129e-01 | 0.881 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.316129e-01 | 0.881 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.316129e-01 | 0.881 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.316129e-01 | 0.881 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.614887e-01 | 0.792 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.614887e-01 | 0.792 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.614887e-01 | 0.792 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.614887e-01 | 0.792 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.614887e-01 | 0.792 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.321793e-01 | 0.634 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.321793e-01 | 0.634 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.321793e-01 | 0.634 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.321793e-01 | 0.634 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.321793e-01 | 0.634 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.321793e-01 | 0.634 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.321793e-01 | 0.634 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.573330e-01 | 0.803 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.573330e-01 | 0.803 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.573330e-01 | 0.803 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 1.885019e-01 | 0.725 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.476471e-01 | 0.831 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 2.204067e-01 | 0.657 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.204067e-01 | 0.657 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.204067e-01 | 0.657 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.685931e-01 | 0.773 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.685931e-01 | 0.773 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.685931e-01 | 0.773 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.685931e-01 | 0.773 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.685931e-01 | 0.773 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.685931e-01 | 0.773 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.685931e-01 | 0.773 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 2.527022e-01 | 0.597 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.473499e-01 | 0.832 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.473499e-01 | 0.832 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.127246e-01 | 0.672 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.808113e-01 | 0.743 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.356436e-01 | 0.628 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.690011e-01 | 0.772 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.690011e-01 | 0.772 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.690011e-01 | 0.772 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.451058e-01 | 0.838 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.589633e-01 | 0.587 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.164935e-01 | 0.665 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.164935e-01 | 0.665 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.835472e-01 | 0.736 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.985320e-01 | 0.702 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.564068e-01 | 0.806 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.139170e-01 | 0.670 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.335202e-01 | 0.874 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.851924e-01 | 0.732 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.149866e-01 | 0.668 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.149866e-01 | 0.668 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.302210e-01 | 0.638 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.392952e-01 | 0.856 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.392952e-01 | 0.856 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.313936e-01 | 0.636 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.424006e-01 | 0.615 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.209133e-01 | 0.656 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.407603e-01 | 0.618 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.651306e-01 | 0.782 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.578182e-01 | 0.802 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.570688e-01 | 0.804 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.353099e-01 | 0.869 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.946213e-01 | 0.711 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.164935e-01 | 0.665 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.413739e-01 | 0.850 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.789867e-01 | 0.747 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.906362e-01 | 0.720 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.353099e-01 | 0.869 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.139170e-01 | 0.670 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.341875e-01 | 0.630 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.356436e-01 | 0.628 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.789028e-01 | 0.747 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.789028e-01 | 0.747 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.506416e-01 | 0.601 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.789028e-01 | 0.747 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.808113e-01 | 0.743 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.642362e-01 | 0.785 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.946213e-01 | 0.711 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.565568e-01 | 0.805 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.413739e-01 | 0.850 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.620765e-01 | 0.582 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.527022e-01 | 0.597 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.694462e-01 | 0.771 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 2.477979e-01 | 0.606 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.573330e-01 | 0.803 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.356436e-01 | 0.628 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.456761e-01 | 0.837 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.564068e-01 | 0.806 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.139170e-01 | 0.670 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.906362e-01 | 0.720 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.620765e-01 | 0.582 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.149866e-01 | 0.668 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.985320e-01 | 0.702 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.335785e-01 | 0.874 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.542694e-01 | 0.812 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.363510e-01 | 0.865 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.456341e-01 | 0.837 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.808113e-01 | 0.743 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.984075e-01 | 0.702 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.953511e-01 | 0.709 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.510828e-01 | 0.821 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.330359e-01 | 0.633 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.690011e-01 | 0.772 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.149866e-01 | 0.668 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.476824e-01 | 0.606 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.296628e-01 | 0.639 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.467643e-01 | 0.833 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.712730e-01 | 0.766 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.594427e-01 | 0.797 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.321793e-01 | 0.634 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.476471e-01 | 0.831 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.476471e-01 | 0.831 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 1.637704e-01 | 0.786 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.356436e-01 | 0.628 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.335785e-01 | 0.874 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.541921e-01 | 0.812 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.535848e-01 | 0.596 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.394856e-01 | 0.855 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.413739e-01 | 0.850 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.072234e-01 | 0.684 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.934179e-01 | 0.714 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.087558e-01 | 0.680 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.725195e-01 | 0.763 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.620765e-01 | 0.582 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.350267e-01 | 0.870 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.350267e-01 | 0.870 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.392109e-01 | 0.621 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.577461e-01 | 0.589 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.570688e-01 | 0.804 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.407962e-01 | 0.618 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.906362e-01 | 0.720 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.644857e-01 | 0.784 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.463770e-01 | 0.608 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 1.587706e-01 | 0.799 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.367076e-01 | 0.626 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.573330e-01 | 0.803 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.903308e-01 | 0.720 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.356436e-01 | 0.628 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.353099e-01 | 0.869 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.296628e-01 | 0.639 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.662728e-01 | 0.575 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.674875e-01 | 0.776 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.789028e-01 | 0.747 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.510828e-01 | 0.821 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.510828e-01 | 0.821 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.510828e-01 | 0.821 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.510828e-01 | 0.821 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.031033e-01 | 0.692 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.510828e-01 | 0.821 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.573330e-01 | 0.803 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.204067e-01 | 0.657 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.527022e-01 | 0.597 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.527022e-01 | 0.597 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.226238e-01 | 0.652 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.594427e-01 | 0.797 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.662728e-01 | 0.575 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.203903e-01 | 0.657 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.353099e-01 | 0.869 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.906362e-01 | 0.720 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.620765e-01 | 0.582 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.016675e-01 | 0.695 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.392952e-01 | 0.856 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.779337e-01 | 0.750 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.356436e-01 | 0.628 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.697230e-01 | 0.770 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.984075e-01 | 0.702 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.984075e-01 | 0.702 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.412052e-01 | 0.618 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.114454e-01 | 0.675 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.226238e-01 | 0.652 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.656344e-01 | 0.576 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.666906e-01 | 0.574 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.666906e-01 | 0.574 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.695290e-01 | 0.569 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.730355e-01 | 0.564 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.730355e-01 | 0.564 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.764356e-01 | 0.558 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.786431e-01 | 0.555 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.825658e-01 | 0.549 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.825658e-01 | 0.549 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.830354e-01 | 0.548 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.850959e-01 | 0.545 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.850959e-01 | 0.545 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.850959e-01 | 0.545 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.850959e-01 | 0.545 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.850959e-01 | 0.545 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.891315e-01 | 0.539 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.928961e-01 | 0.533 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.937248e-01 | 0.532 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.937248e-01 | 0.532 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.953888e-01 | 0.530 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.954529e-01 | 0.530 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 2.954529e-01 | 0.530 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.954529e-01 | 0.530 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.957753e-01 | 0.529 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.969141e-01 | 0.527 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.969141e-01 | 0.527 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 2.969141e-01 | 0.527 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.969141e-01 | 0.527 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.969141e-01 | 0.527 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 2.969141e-01 | 0.527 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.969141e-01 | 0.527 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.969141e-01 | 0.527 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.971965e-01 | 0.527 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.998447e-01 | 0.523 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.038178e-01 | 0.517 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.063408e-01 | 0.514 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.063408e-01 | 0.514 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.063408e-01 | 0.514 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.100451e-01 | 0.509 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.117263e-01 | 0.506 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.119981e-01 | 0.506 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.119981e-01 | 0.506 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.119981e-01 | 0.506 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.124035e-01 | 0.505 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.173419e-01 | 0.498 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.173419e-01 | 0.498 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.173419e-01 | 0.498 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.173419e-01 | 0.498 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.173419e-01 | 0.498 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.173419e-01 | 0.498 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.173419e-01 | 0.498 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.173586e-01 | 0.498 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.180730e-01 | 0.497 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.293950e-01 | 0.482 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.293950e-01 | 0.482 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.294778e-01 | 0.482 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.294778e-01 | 0.482 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.294778e-01 | 0.482 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.294778e-01 | 0.482 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.301860e-01 | 0.481 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.301860e-01 | 0.481 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.301860e-01 | 0.481 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.301860e-01 | 0.481 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.301860e-01 | 0.481 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.301860e-01 | 0.481 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.301860e-01 | 0.481 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.301860e-01 | 0.481 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.316787e-01 | 0.479 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.340200e-01 | 0.476 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.352916e-01 | 0.475 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.407941e-01 | 0.468 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.410901e-01 | 0.467 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.410901e-01 | 0.467 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.453974e-01 | 0.462 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.492353e-01 | 0.457 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.492353e-01 | 0.457 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.492353e-01 | 0.457 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.492353e-01 | 0.457 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.492353e-01 | 0.457 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.492353e-01 | 0.457 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.492353e-01 | 0.457 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.540071e-01 | 0.451 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.540071e-01 | 0.451 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.549912e-01 | 0.450 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.554528e-01 | 0.449 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.561947e-01 | 0.448 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.561947e-01 | 0.448 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.561947e-01 | 0.448 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.561947e-01 | 0.448 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.561947e-01 | 0.448 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.608721e-01 | 0.443 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.638495e-01 | 0.439 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.638495e-01 | 0.439 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.638495e-01 | 0.439 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.711604e-01 | 0.430 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.711604e-01 | 0.430 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.719576e-01 | 0.430 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.719576e-01 | 0.430 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.753452e-01 | 0.426 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.772087e-01 | 0.423 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.775650e-01 | 0.423 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.775887e-01 | 0.423 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.806062e-01 | 0.420 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.806062e-01 | 0.420 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.806062e-01 | 0.420 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.816576e-01 | 0.418 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.829138e-01 | 0.417 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.869444e-01 | 0.412 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.908588e-01 | 0.408 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.909673e-01 | 0.408 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.948023e-01 | 0.404 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.982847e-01 | 0.400 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.012399e-01 | 0.397 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.012399e-01 | 0.397 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.012399e-01 | 0.397 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.012399e-01 | 0.397 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.029061e-01 | 0.395 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.029061e-01 | 0.395 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.059303e-01 | 0.392 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.104657e-01 | 0.387 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.104803e-01 | 0.387 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.104803e-01 | 0.387 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.104803e-01 | 0.387 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.104803e-01 | 0.387 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.104803e-01 | 0.387 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.104803e-01 | 0.387 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.104803e-01 | 0.387 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.104803e-01 | 0.387 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.113163e-01 | 0.386 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.113163e-01 | 0.386 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.113163e-01 | 0.386 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.113163e-01 | 0.386 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.113163e-01 | 0.386 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.113163e-01 | 0.386 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.154438e-01 | 0.381 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.218093e-01 | 0.375 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.260348e-01 | 0.371 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.299374e-01 | 0.367 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.313803e-01 | 0.365 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.325229e-01 | 0.364 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.328619e-01 | 0.364 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.337449e-01 | 0.363 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.337449e-01 | 0.363 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.412540e-01 | 0.355 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.412540e-01 | 0.355 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.412540e-01 | 0.355 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.462345e-01 | 0.350 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.474446e-01 | 0.349 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.474446e-01 | 0.349 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.474446e-01 | 0.349 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.482896e-01 | 0.348 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.492334e-01 | 0.348 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.492334e-01 | 0.348 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.492334e-01 | 0.348 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.492334e-01 | 0.348 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.492334e-01 | 0.348 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.492334e-01 | 0.348 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.566745e-01 | 0.340 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 4.601915e-01 | 0.337 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.601915e-01 | 0.337 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.601915e-01 | 0.337 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.601915e-01 | 0.337 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.601915e-01 | 0.337 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.601915e-01 | 0.337 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.601915e-01 | 0.337 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.601915e-01 | 0.337 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.601915e-01 | 0.337 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.601915e-01 | 0.337 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.601915e-01 | 0.337 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.601915e-01 | 0.337 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.601915e-01 | 0.337 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.623000e-01 | 0.335 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.623000e-01 | 0.335 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.663285e-01 | 0.331 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.682261e-01 | 0.330 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.683167e-01 | 0.329 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.683167e-01 | 0.329 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.700089e-01 | 0.328 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.700089e-01 | 0.328 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.700089e-01 | 0.328 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.703313e-01 | 0.328 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.703313e-01 | 0.328 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.703313e-01 | 0.328 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.703313e-01 | 0.328 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.703313e-01 | 0.328 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.703313e-01 | 0.328 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.703313e-01 | 0.328 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.768742e-01 | 0.322 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.871531e-01 | 0.312 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.877878e-01 | 0.312 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.877878e-01 | 0.312 | 1 | 1 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.917532e-01 | 0.308 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.921475e-01 | 0.308 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.944033e-01 | 0.306 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.950723e-01 | 0.305 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.982729e-01 | 0.303 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.984804e-01 | 0.302 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.984804e-01 | 0.302 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.984804e-01 | 0.302 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.984804e-01 | 0.302 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.994932e-01 | 0.301 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.994932e-01 | 0.301 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.037833e-01 | 0.298 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.057135e-01 | 0.296 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.057135e-01 | 0.296 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.057135e-01 | 0.296 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.057135e-01 | 0.296 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.057135e-01 | 0.296 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.057135e-01 | 0.296 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.057135e-01 | 0.296 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.057135e-01 | 0.296 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.057135e-01 | 0.296 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.057135e-01 | 0.296 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.057135e-01 | 0.296 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.057135e-01 | 0.296 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.092434e-01 | 0.293 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.092434e-01 | 0.293 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.138184e-01 | 0.289 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.138955e-01 | 0.289 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.157777e-01 | 0.288 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 5.157777e-01 | 0.288 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.180593e-01 | 0.286 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 5.239649e-01 | 0.281 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.251367e-01 | 0.280 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.251367e-01 | 0.280 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.256512e-01 | 0.279 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.256512e-01 | 0.279 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.256512e-01 | 0.279 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.256512e-01 | 0.279 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.256512e-01 | 0.279 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.256512e-01 | 0.279 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.256512e-01 | 0.279 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.312641e-01 | 0.275 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.349857e-01 | 0.272 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.349857e-01 | 0.272 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.349857e-01 | 0.272 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.384163e-01 | 0.269 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.409982e-01 | 0.267 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.473992e-01 | 0.262 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.473992e-01 | 0.262 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.473992e-01 | 0.262 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.473992e-01 | 0.262 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.473992e-01 | 0.262 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.473992e-01 | 0.262 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.473992e-01 | 0.262 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.473992e-01 | 0.262 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.473992e-01 | 0.262 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.473992e-01 | 0.262 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.473992e-01 | 0.262 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 5.473992e-01 | 0.262 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.473992e-01 | 0.262 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.473992e-01 | 0.262 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.476510e-01 | 0.261 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.518086e-01 | 0.258 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.518086e-01 | 0.258 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.518086e-01 | 0.258 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 5.527198e-01 | 0.257 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.556195e-01 | 0.255 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.556195e-01 | 0.255 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.556195e-01 | 0.255 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.594579e-01 | 0.252 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.632049e-01 | 0.249 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.654659e-01 | 0.248 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.691692e-01 | 0.245 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.702869e-01 | 0.244 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.756948e-01 | 0.240 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.766565e-01 | 0.239 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.768236e-01 | 0.239 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.769301e-01 | 0.239 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.769301e-01 | 0.239 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.769301e-01 | 0.239 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 5.769301e-01 | 0.239 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.799104e-01 | 0.237 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.852294e-01 | 0.233 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.855715e-01 | 0.232 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.855715e-01 | 0.232 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.855715e-01 | 0.232 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.855715e-01 | 0.232 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.855715e-01 | 0.232 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.855715e-01 | 0.232 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.855715e-01 | 0.232 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.855715e-01 | 0.232 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.855715e-01 | 0.232 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.855715e-01 | 0.232 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.855715e-01 | 0.232 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.855715e-01 | 0.232 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.934668e-01 | 0.227 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.934668e-01 | 0.227 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.951921e-01 | 0.225 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.951921e-01 | 0.225 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.991301e-01 | 0.222 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.010045e-01 | 0.221 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.010045e-01 | 0.221 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.010045e-01 | 0.221 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.077580e-01 | 0.216 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.098747e-01 | 0.215 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.140959e-01 | 0.212 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.203224e-01 | 0.207 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.205264e-01 | 0.207 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.205264e-01 | 0.207 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.205264e-01 | 0.207 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.205264e-01 | 0.207 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.205264e-01 | 0.207 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.205264e-01 | 0.207 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.205264e-01 | 0.207 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.205264e-01 | 0.207 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.205264e-01 | 0.207 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.205264e-01 | 0.207 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.205264e-01 | 0.207 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.208506e-01 | 0.207 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.208506e-01 | 0.207 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.208506e-01 | 0.207 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.240297e-01 | 0.205 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.240297e-01 | 0.205 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.240297e-01 | 0.205 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.258684e-01 | 0.204 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.258684e-01 | 0.204 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.317230e-01 | 0.199 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.317230e-01 | 0.199 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.323197e-01 | 0.199 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.348289e-01 | 0.197 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.365965e-01 | 0.196 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.414385e-01 | 0.193 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.460113e-01 | 0.190 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.460113e-01 | 0.190 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.460113e-01 | 0.190 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.460113e-01 | 0.190 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.460113e-01 | 0.190 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.460113e-01 | 0.190 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.460113e-01 | 0.190 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.460113e-01 | 0.190 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.460113e-01 | 0.190 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.500826e-01 | 0.187 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.500826e-01 | 0.187 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.518038e-01 | 0.186 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.525350e-01 | 0.185 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.525350e-01 | 0.185 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.525350e-01 | 0.185 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.525350e-01 | 0.185 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.525350e-01 | 0.185 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.525350e-01 | 0.185 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.525350e-01 | 0.185 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.525350e-01 | 0.185 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.525350e-01 | 0.185 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.525350e-01 | 0.185 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.525350e-01 | 0.185 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.525350e-01 | 0.185 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.525350e-01 | 0.185 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.601975e-01 | 0.180 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.637234e-01 | 0.178 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.669617e-01 | 0.176 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.669836e-01 | 0.176 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.671542e-01 | 0.176 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.671542e-01 | 0.176 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.712800e-01 | 0.173 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.818454e-01 | 0.166 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.818454e-01 | 0.166 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.818454e-01 | 0.166 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.818454e-01 | 0.166 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.818454e-01 | 0.166 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 6.818454e-01 | 0.166 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.818454e-01 | 0.166 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.836091e-01 | 0.165 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.836091e-01 | 0.165 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 6.836091e-01 | 0.165 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.836091e-01 | 0.165 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.855423e-01 | 0.164 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.889408e-01 | 0.162 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.891410e-01 | 0.162 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.993625e-01 | 0.155 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.994491e-01 | 0.155 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.994491e-01 | 0.155 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.994491e-01 | 0.155 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.007180e-01 | 0.154 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.018685e-01 | 0.154 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.018685e-01 | 0.154 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.058429e-01 | 0.151 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.058429e-01 | 0.151 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.086850e-01 | 0.150 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.086850e-01 | 0.150 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.086850e-01 | 0.150 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.086850e-01 | 0.150 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.086850e-01 | 0.150 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.086850e-01 | 0.150 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.086850e-01 | 0.150 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.086850e-01 | 0.150 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.146786e-01 | 0.146 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.162142e-01 | 0.145 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.238213e-01 | 0.140 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.238213e-01 | 0.140 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.238213e-01 | 0.140 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.238213e-01 | 0.140 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.255703e-01 | 0.139 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.256763e-01 | 0.139 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.256763e-01 | 0.139 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.282443e-01 | 0.138 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.293040e-01 | 0.137 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.293040e-01 | 0.137 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.312001e-01 | 0.136 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.325702e-01 | 0.135 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.325702e-01 | 0.135 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.332618e-01 | 0.135 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.332618e-01 | 0.135 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.332618e-01 | 0.135 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.332618e-01 | 0.135 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.332618e-01 | 0.135 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.332618e-01 | 0.135 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.332618e-01 | 0.135 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.332618e-01 | 0.135 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.332618e-01 | 0.135 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.369136e-01 | 0.133 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.381733e-01 | 0.132 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.391270e-01 | 0.131 | 1 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.396334e-01 | 0.131 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.396334e-01 | 0.131 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.408613e-01 | 0.130 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.557665e-01 | 0.122 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.557665e-01 | 0.122 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.557665e-01 | 0.122 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.557665e-01 | 0.122 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.557665e-01 | 0.122 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.557665e-01 | 0.122 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.557665e-01 | 0.122 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.557665e-01 | 0.122 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.557665e-01 | 0.122 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.557665e-01 | 0.122 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.557665e-01 | 0.122 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.557665e-01 | 0.122 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.566057e-01 | 0.121 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.566057e-01 | 0.121 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.567774e-01 | 0.121 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.569935e-01 | 0.121 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.569935e-01 | 0.121 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.569935e-01 | 0.121 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.569935e-01 | 0.121 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.569935e-01 | 0.121 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.569935e-01 | 0.121 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.569935e-01 | 0.121 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.569935e-01 | 0.121 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.585269e-01 | 0.120 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.696469e-01 | 0.114 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.696469e-01 | 0.114 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.696469e-01 | 0.114 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.696976e-01 | 0.114 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 7.722496e-01 | 0.112 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.722496e-01 | 0.112 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.722496e-01 | 0.112 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.722496e-01 | 0.112 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.730695e-01 | 0.112 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.763737e-01 | 0.110 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.763737e-01 | 0.110 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.763737e-01 | 0.110 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.763737e-01 | 0.110 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 7.763737e-01 | 0.110 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.763737e-01 | 0.110 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.763737e-01 | 0.110 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.763737e-01 | 0.110 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.763737e-01 | 0.110 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.819545e-01 | 0.107 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.866626e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.866626e-01 | 0.104 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.924359e-01 | 0.101 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.924359e-01 | 0.101 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.924359e-01 | 0.101 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.952433e-01 | 0.099 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 7.952433e-01 | 0.099 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.952433e-01 | 0.099 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.952433e-01 | 0.099 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.952433e-01 | 0.099 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.952433e-01 | 0.099 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.952433e-01 | 0.099 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.952433e-01 | 0.099 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.952433e-01 | 0.099 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.977161e-01 | 0.098 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.002661e-01 | 0.097 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.002661e-01 | 0.097 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.125217e-01 | 0.090 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.125217e-01 | 0.090 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.125217e-01 | 0.090 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.125217e-01 | 0.090 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.125217e-01 | 0.090 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.125217e-01 | 0.090 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.130941e-01 | 0.090 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.130941e-01 | 0.090 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.132293e-01 | 0.090 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.198024e-01 | 0.086 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.206731e-01 | 0.086 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.236867e-01 | 0.084 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.251805e-01 | 0.083 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.251805e-01 | 0.083 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.251805e-01 | 0.083 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.251805e-01 | 0.083 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.251805e-01 | 0.083 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.258494e-01 | 0.083 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.283430e-01 | 0.082 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.283430e-01 | 0.082 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.283430e-01 | 0.082 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.283430e-01 | 0.082 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.317077e-01 | 0.080 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.317208e-01 | 0.080 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.355657e-01 | 0.078 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.355657e-01 | 0.078 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.355657e-01 | 0.078 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.365591e-01 | 0.078 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.365591e-01 | 0.078 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.365591e-01 | 0.078 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.365591e-01 | 0.078 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.394540e-01 | 0.076 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.402036e-01 | 0.076 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.428300e-01 | 0.074 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.428300e-01 | 0.074 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.428300e-01 | 0.074 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.428300e-01 | 0.074 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.428300e-01 | 0.074 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.428300e-01 | 0.074 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.428300e-01 | 0.074 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.448109e-01 | 0.073 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.475393e-01 | 0.072 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.502195e-01 | 0.070 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.524151e-01 | 0.069 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.536016e-01 | 0.069 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.560952e-01 | 0.067 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.560952e-01 | 0.067 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.560952e-01 | 0.067 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.634127e-01 | 0.064 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.634127e-01 | 0.064 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.644141e-01 | 0.063 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.662504e-01 | 0.062 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.667786e-01 | 0.062 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.682415e-01 | 0.061 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.682415e-01 | 0.061 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.682415e-01 | 0.061 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.698849e-01 | 0.061 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.704798e-01 | 0.060 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.738442e-01 | 0.059 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.756530e-01 | 0.058 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.756530e-01 | 0.058 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.793633e-01 | 0.056 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.793633e-01 | 0.056 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.793633e-01 | 0.056 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.793633e-01 | 0.056 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.793633e-01 | 0.056 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.793633e-01 | 0.056 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.795327e-01 | 0.056 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.799172e-01 | 0.056 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.823847e-01 | 0.054 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.839792e-01 | 0.054 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.839792e-01 | 0.054 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.839809e-01 | 0.054 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.895468e-01 | 0.051 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.895468e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.895468e-01 | 0.051 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.895468e-01 | 0.051 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.895468e-01 | 0.051 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.913101e-01 | 0.050 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.917865e-01 | 0.050 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.917865e-01 | 0.050 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.977160e-01 | 0.047 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.988713e-01 | 0.046 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 8.988713e-01 | 0.046 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.988713e-01 | 0.046 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.988713e-01 | 0.046 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 8.988713e-01 | 0.046 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.988713e-01 | 0.046 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 8.988713e-01 | 0.046 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.988713e-01 | 0.046 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.037243e-01 | 0.044 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.037799e-01 | 0.044 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.059562e-01 | 0.043 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.074091e-01 | 0.042 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.074091e-01 | 0.042 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.074091e-01 | 0.042 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.074091e-01 | 0.042 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.074091e-01 | 0.042 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.074091e-01 | 0.042 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.083841e-01 | 0.042 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.149417e-01 | 0.039 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.149417e-01 | 0.039 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.152266e-01 | 0.038 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.152266e-01 | 0.038 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.152266e-01 | 0.038 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.152266e-01 | 0.038 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.152266e-01 | 0.038 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.152266e-01 | 0.038 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.152266e-01 | 0.038 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.152266e-01 | 0.038 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.152266e-01 | 0.038 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.152266e-01 | 0.038 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.168260e-01 | 0.038 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.183752e-01 | 0.037 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.183752e-01 | 0.037 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.183752e-01 | 0.037 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.183752e-01 | 0.037 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.183752e-01 | 0.037 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.200808e-01 | 0.036 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.202097e-01 | 0.036 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.223845e-01 | 0.035 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.223845e-01 | 0.035 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.223845e-01 | 0.035 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.223845e-01 | 0.035 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.223845e-01 | 0.035 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.246572e-01 | 0.034 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.289384e-01 | 0.032 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.289384e-01 | 0.032 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.289384e-01 | 0.032 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.289384e-01 | 0.032 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.289384e-01 | 0.032 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.289384e-01 | 0.032 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.289384e-01 | 0.032 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.289384e-01 | 0.032 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.292390e-01 | 0.032 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.292390e-01 | 0.032 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.292390e-01 | 0.032 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.292390e-01 | 0.032 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.330218e-01 | 0.030 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.334634e-01 | 0.030 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.337997e-01 | 0.030 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.349392e-01 | 0.029 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.349392e-01 | 0.029 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.349392e-01 | 0.029 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.349392e-01 | 0.029 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.349392e-01 | 0.029 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.349392e-01 | 0.029 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.349392e-01 | 0.029 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.378702e-01 | 0.028 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.387255e-01 | 0.027 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.404336e-01 | 0.027 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.404336e-01 | 0.027 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.404336e-01 | 0.027 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.404336e-01 | 0.027 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.407308e-01 | 0.027 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.417083e-01 | 0.026 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.418977e-01 | 0.026 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.430033e-01 | 0.025 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.430033e-01 | 0.025 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.430033e-01 | 0.025 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.430739e-01 | 0.025 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.454643e-01 | 0.024 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.454643e-01 | 0.024 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.454643e-01 | 0.024 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.454643e-01 | 0.024 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.454643e-01 | 0.024 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.454643e-01 | 0.024 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.459203e-01 | 0.024 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.469960e-01 | 0.024 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.472676e-01 | 0.024 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.500704e-01 | 0.022 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.500704e-01 | 0.022 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.500704e-01 | 0.022 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.507211e-01 | 0.022 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.507211e-01 | 0.022 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.542877e-01 | 0.020 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.542877e-01 | 0.020 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.542877e-01 | 0.020 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.574347e-01 | 0.019 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.581491e-01 | 0.019 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.584007e-01 | 0.018 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.585290e-01 | 0.018 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.604538e-01 | 0.018 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.604779e-01 | 0.018 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.632669e-01 | 0.016 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.641410e-01 | 0.016 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.649214e-01 | 0.016 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.649214e-01 | 0.016 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.658329e-01 | 0.015 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.658329e-01 | 0.015 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.658329e-01 | 0.015 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.658871e-01 | 0.015 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.675390e-01 | 0.014 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.678850e-01 | 0.014 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.679478e-01 | 0.014 | 0 | 0 |
| Translation | R-HSA-72766 | 9.684649e-01 | 0.014 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.696588e-01 | 0.013 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.704486e-01 | 0.013 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.705983e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.705984e-01 | 0.013 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.705984e-01 | 0.013 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.706957e-01 | 0.013 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.716165e-01 | 0.013 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.730827e-01 | 0.012 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.730827e-01 | 0.012 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.730827e-01 | 0.012 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.730827e-01 | 0.012 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.744212e-01 | 0.011 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.746788e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.753573e-01 | 0.011 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.753573e-01 | 0.011 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.753573e-01 | 0.011 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.767960e-01 | 0.010 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.774397e-01 | 0.010 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.776804e-01 | 0.010 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.791774e-01 | 0.009 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.793463e-01 | 0.009 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.793463e-01 | 0.009 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.793463e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.793463e-01 | 0.009 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.793463e-01 | 0.009 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.793463e-01 | 0.009 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.793463e-01 | 0.009 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.797907e-01 | 0.009 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.809217e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.809217e-01 | 0.008 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.810679e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.810679e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.812900e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.812900e-01 | 0.008 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.826266e-01 | 0.008 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.826900e-01 | 0.008 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.841531e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.850744e-01 | 0.007 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.854927e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.854927e-01 | 0.006 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.858327e-01 | 0.006 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.859749e-01 | 0.006 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.867191e-01 | 0.006 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.867191e-01 | 0.006 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.867191e-01 | 0.006 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.878419e-01 | 0.005 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.878419e-01 | 0.005 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.878419e-01 | 0.005 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.888698e-01 | 0.005 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.898108e-01 | 0.004 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.898167e-01 | 0.004 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.898167e-01 | 0.004 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.900186e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.919180e-01 | 0.004 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.919696e-01 | 0.004 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.921833e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.923188e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.923188e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.925192e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.928443e-01 | 0.003 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.942148e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.944745e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.945108e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.956535e-01 | 0.002 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.956535e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.956603e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.956603e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.962359e-01 | 0.002 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.967610e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.967703e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.967703e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.970245e-01 | 0.001 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.970436e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.972938e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.975228e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.977325e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.978622e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.978994e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.978994e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.981001e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.983004e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.985997e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.987415e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.987523e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.987792e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.988817e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.989772e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.989924e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.990131e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.990352e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.990638e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.990638e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.990638e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.991316e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.991316e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.992821e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.993538e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.995389e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.996137e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.996490e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997049e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997448e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997549e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997740e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998882e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999061e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999216e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999325e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999343e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999430e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999556e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999579e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999647e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999662e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999664e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999666e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999739e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999773e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999907e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999927e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999953e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999954e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999961e-01 | 0.000 | 1 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999974e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999976e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999981e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999987e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999988e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999989e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999995e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999997e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999997e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |